Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Exp Neurol ; 326: 113175, 2020 04.
Article in English | MEDLINE | ID: mdl-31923390

ABSTRACT

Salicylate intoxication is a cause of tinnitus and comorbidly associated with anxiety in humans. In a previous work, we showed that salicylate induces anxiety-like behavior and hippocampal type 2 theta oscillations (theta2) in mice. Here we investigate if the anxiogenic effect of salicylate is dependent on age and previous tinnitus experience. We also tested whether a single dose of DMT can prevent this effect. Using microwire electrode arrays, we recorded local field potential in young (4-5- month-old) and old (11-13-month-old) mice to study the electrophysiological effect of tinnitus in the ventral hippocampus (vHipp) and medial prefrontal cortex (mPFC) in an open field arena and elevated plus maze 1h after salicylate (300mg/kg) injection. We found that anxiety-like behavior and increase in theta2 oscillations (4-6 Hz), following salicylate pre-treatment, only occurs in young (normal hearing) mice. We also show that theta2 and slow gamma oscillations increase in the vHipp and mPFC in a complementary manner during anxiety tests in the presence of salicylate. Finally, we show that pre-treating mice with a single dose of the hallucinogenic 5-MeO-DMT prevents anxiety-like behavior and the increase in theta2 and slow gamma oscillations after salicylate injection in normal hearing young mice. This work further support the hypothesis that anxiety-like behavior after salicylate injection is triggered by tinnitus and require normal hearing. Moreover, our results show that hallucinogenic compounds can be effective in treating tinnitus-related anxiety.


Subject(s)
Aging/psychology , Anxiety/chemically induced , Anxiety/psychology , Hallucinogens/therapeutic use , Methoxydimethyltryptamines/therapeutic use , Salicylates , Animals , Anxiety/prevention & control , Behavior, Animal , Electroencephalography/drug effects , Evoked Potentials, Auditory, Brain Stem , Hearing Loss, Noise-Induced/complications , Hippocampus/physiopathology , Male , Mice , Mice, Inbred C57BL , Microelectrodes , Motor Activity , Prefrontal Cortex/physiopathology , Salicylates/antagonists & inhibitors , Tinnitus/chemically induced , Tinnitus/physiopathology , Tinnitus/psychology
2.
Sci Rep ; 9(1): 16622, 2019 11 12.
Article in English | MEDLINE | ID: mdl-31719599

ABSTRACT

The study of pharmacological interactions between herbal remedies and conventional drugs is important because consuming traditional herbal remedies as supplements or alternative medicine is fairly common and their concomitant administration with prescribed drugs could either have a favorable or unfavorable effect. Therefore, this work aims to determine the pharmacological interactions of a turmeric acetone extract (TAE) and its main metabolite (curcumin) with common anti-ulcer drugs (ranitidine and bismuth subsalicylate), using an ethanol-induced ulcer model in Wistar rats. The analysis of the interactions was carried out via the Combination Index-Isobologram Equation method. The combination index (CI) calculated at 0.5 of the affected fraction (fa) indicated that the TAE or curcumin in combination with ranitidine had a subadditive interaction. The results suggest that this antagonistic mechanism is associated to the mucoadhesion of curcumin and the TAE, determined by rheological measurements. Contrastingly, both the TAE and curcumin combined with bismuth subsalicylate had an additive relationship, which means that there is no pharmacological interaction. This agrees with the normalized isobolograms obtained for each combination. The results of this study suggest that mucoadhesion of curcumin and the TAE could interfere in the effectiveness of ranitidine, and even other drugs.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Bismuth/therapeutic use , Curcumin/pharmacology , Ethanol/adverse effects , Organometallic Compounds/therapeutic use , Plant Extracts/pharmacology , Ranitidine/therapeutic use , Salicylates/therapeutic use , Stomach Ulcer/prevention & control , Animals , Anti-Ulcer Agents/antagonists & inhibitors , Curcuma , Disease Models, Animal , Drug Interactions , Gastric Mucosa/drug effects , Herb-Drug Interactions , Male , Organometallic Compounds/antagonists & inhibitors , Ranitidine/antagonists & inhibitors , Rats , Rats, Wistar , Salicylates/antagonists & inhibitors , Stomach Ulcer/chemically induced
3.
Biochem J ; 374(Pt 2): 481-8, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-12793857

ABSTRACT

Naproxen, sulindac and salicylate, three NSAIDs (non-steroidal anti-inflammatory drugs), were cytotoxic to human colorectal cancer cells in culture. Toxicity was accompanied by significant depletion of intracellular polyamine content. Inhibition of ornithine decarboxylase (the first enzyme of the polyamine biosynthetic pathway), induction of polyamine oxidase and spermidine/spermine N(1)-acetyltransferase (the enzymes responsible for polyamine catabolism) and induction of polyamine export all contributed to the decreased intracellular polyamine content. Morphological examination of the cells showed typical signs of apoptosis, and this was confirmed by DNA fragmentation and measurement of caspase-3-like activity. Re-addition of spermidine to the cells partially prevented apoptosis and recovered the cell number. Thus polyamines appear to be an integral part of the signalling pathway mediating NSAID toxicity in human colorectal cancer cells, and may therefore also be important in cancer chemoprevention in humans.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/antagonists & inhibitors , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Colorectal Neoplasms/metabolism , Polyamines/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Apoptosis/drug effects , Cell Division/drug effects , Cell Membrane/drug effects , Cell Survival/drug effects , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/pathology , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Fluorescent Dyes/metabolism , Humans , Indoles/metabolism , Intercalating Agents/metabolism , Naproxen/administration & dosage , Naproxen/antagonists & inhibitors , Naproxen/metabolism , Naproxen/toxicity , Polyamines/metabolism , Putrescine/metabolism , Putrescine/pharmacology , Putrescine/physiology , Salicylates/administration & dosage , Salicylates/antagonists & inhibitors , Salicylates/metabolism , Salicylates/toxicity , Spermidine/metabolism , Spermidine/pharmacology , Spermidine/physiology , Spermine/metabolism , Spermine/pharmacology , Spermine/physiology , Sulindac/administration & dosage , Sulindac/antagonists & inhibitors , Sulindac/metabolism , Sulindac/toxicity , Tumor Cells, Cultured
4.
Rev Port Cardiol ; 21(5): 541-51, 2002 May.
Article in English, Portuguese | MEDLINE | ID: mdl-12174518

ABSTRACT

UNLABELLED: Few trials have studied platelet activity during oral anticoagulation and all show a tendency for platelet aggregation to increase. This adverse effect has also been shown in some patients treated with unfractionated heparin, the so-called white clot syndrome. We studied platelet aggregation in patients with atrial fibrillation enrolled in the NASPEAF study and receiving antiaggregant, anticoagulant and both treatments. METHODS: 15 healthy control subjects (group C) and 99 patients were enrolled, the latter receiving 4 different antithrombotic regimens for platelet aggregation: group 1, 600 mg of the antiplatelet drug triflusal; group 2, anticoagulation for an INR of 2-3; and both treatments with 2 different levels of anticoagulation, mean INR of 1.85 (group 3) and of 2.15 (group 4). The same amounts of the agonists ADP, arachidonic acid and collagen were used in all tests. For statistical analysis we used the interval in min, from the addition of the agonist to the beginning of aggregation and the % of aggregation at 5 and 8 min. RESULTS: After arachidonic acid was given, the interval to the beginning of aggregation was shorter in group 2 than in group C: 0.6 +/- 0.21 and 1.1 +/- 1.2, and in both was significantly shorter than in the other three receiving antiplatelet drugs alone: group 1 = 1.58 +/- 1.4 or combined with anticoagulants: group 3 = 1.7 +/- 1.7 and group 4 = 2.4 +/- 2.1. The % of aggregation at 5 min, in groups C, 2, 1, 3 and 4 was respectively 48 +/- 24, 43.2 +/- 19, 29.6 +/- 17, 34.8 +/- 22 and 23.2 +/- 22.5. The data showed significantly increased platelet activity in groups C and 2 compared to groups 1, 3 and 4. Group 3 with a low anticoagulation level (mean INR = 1.85) showed a tendency to greater platelet activity than group 1 and 4 with p value = 0.08. CONCLUSIONS: The antiplatelet drug triflusal alone or combined with a therapeutic level of anticoagulation effectively reduces platelet aggregation and is not influenced by anticoagulant treatment. A low level of anticoagulation (INR < 2) shows a tendency to increase platelet activity.


Subject(s)
Acenocoumarol/adverse effects , Anticoagulants/adverse effects , Blood Platelets/drug effects , Platelet Aggregation Inhibitors/adverse effects , Platelet Aggregation , Salicylates/adverse effects , Acenocoumarol/administration & dosage , Acenocoumarol/antagonists & inhibitors , Adenosine Diphosphate/pharmacology , Aged , Analysis of Variance , Anticoagulants/administration & dosage , Anticoagulants/antagonists & inhibitors , Arachidonic Acid/pharmacology , Atrial Fibrillation/blood , Atrial Fibrillation/complications , Collagen/pharmacology , Embolism/blood , Embolism/prevention & control , Female , Humans , Male , Platelet Aggregation Inhibitors/administration & dosage , Salicylates/administration & dosage , Salicylates/antagonists & inhibitors , Time Factors
5.
Nihon Jibiinkoka Gakkai Kaiho ; 101(6): 807-13, 1998 Jun.
Article in Japanese | MEDLINE | ID: mdl-9711081

ABSTRACT

The effects of lidocaine (a local anesthetic known to relieve tinnitus) in a guinea pig animal model of tinnitus in which spontaneous discharge of inferior colliculus (IC) neurons was augmented by intravenous application of salicylate (200 mg/kg) were studied by extracellular recording. The salicylate induced discharge was inhibited by intravenous injection of lidocaine at a concentration (lmg/kg) used clinically for treating tinnitus. IC neurons could be divided into two groups according to the difference in sensitivity to lidocaine, weakly sensitive neurons and highly sensitive neurons. In weakly sensitive neurons, the lidocaine effect lasted for less than five min, and the inhibiton of the discharge of neurons was increased as the latency of response to the sound stimulus became longer. It was considered that lidocaine inhibited the propagation of action potentials by blocking Na+ channels. In highly sensitive neurons, on the other hand, the activity of neurons was almost completely inhibited for longer than 30 min and it might involved different mechanisms. Furthermore, the inhibitory action of lidocaine was stronger in IC neurons discharging at higher frequencies, suggesting a use dependent blocking action of Na+ channels, by lidocaine.


Subject(s)
Anesthetics, Local/pharmacology , Inferior Colliculi/physiopathology , Lidocaine/pharmacology , Neurons, Afferent/drug effects , Salicylates/antagonists & inhibitors , Action Potentials/drug effects , Anesthetics, Local/therapeutic use , Animals , Dose-Response Relationship, Drug , Guinea Pigs , Lidocaine/therapeutic use , Salicylates/adverse effects , Sodium Channels/drug effects , Tinnitus/chemically induced , Tinnitus/drug therapy
12.
Biochem J ; 126(2): 347-50, 1972 Jan.
Article in English | MEDLINE | ID: mdl-4403641

ABSTRACT

1. Salicylate, in concentrations of 0.25mm and above, enhances the basal activity of tyrosine-2-oxoglutarate aminotransferase in homogenates of rat liver incubated in the absence of added pyridoxal 5'-phosphate (endogenous activity). The effect is decreased by increasing the concentration of the cofactor. 2. The intraperitoneal administration of sodium salicylate enhances the activity of rat liver tyrosine aminotransferase; the major effect during the first hour being on the enzyme in the absence of added pyridoxal phosphate. Actinomycin D prevents the induction of the enzyme by cortisol and tryptophan. Induction by pyridoxine or salicylate is 50% inhibited by actinomycin D. The effects of the injections of various combinations of cortisol, pyridoxine and salicylate were also studied in the absence or presence of actinomycin D. 3. It is suggested that salicylate induces rat liver tyrosine aminotransferase by displacing its protein-bound cofactor and that a cofactor-type induction of the hepatic enzyme occurs in pyridoxine-treated rats.


Subject(s)
Liver/enzymology , Salicylates/pharmacology , Tyrosine Transaminase/analysis , Tyrosine Transaminase/biosynthesis , Adrenalectomy , Animals , Dactinomycin/pharmacology , Drug Antagonism , Enzyme Activation , Enzyme Induction/drug effects , Hydrocortisone/antagonists & inhibitors , Hydrocortisone/pharmacology , In Vitro Techniques , Injections, Intraperitoneal , Liver/drug effects , Male , Protein Binding , Pyridoxal Phosphate/pharmacology , Pyridoxine/antagonists & inhibitors , Pyridoxine/pharmacology , Rats , Salicylates/antagonists & inhibitors , Spectrophotometry , Tryptophan/antagonists & inhibitors , Tryptophan/pharmacology , Tyrosine Transaminase/metabolism , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...